ASTANCOLLE, Serenella
 Distribuzione geografica
Continente #
NA - Nord America 2.793
EU - Europa 869
AS - Asia 295
SA - Sud America 2
AF - Africa 1
OC - Oceania 1
Totale 3.961
Nazione #
US - Stati Uniti d'America 2.781
GB - Regno Unito 343
SE - Svezia 150
CN - Cina 121
DE - Germania 112
SG - Singapore 93
UA - Ucraina 74
IT - Italia 59
FI - Finlandia 50
HK - Hong Kong 30
FR - Francia 28
TR - Turchia 28
BG - Bulgaria 25
IN - India 16
CA - Canada 12
BE - Belgio 10
RU - Federazione Russa 8
NL - Olanda 2
PL - Polonia 2
RO - Romania 2
TH - Thailandia 2
AR - Argentina 1
AT - Austria 1
BR - Brasile 1
CZ - Repubblica Ceca 1
IE - Irlanda 1
IR - Iran 1
LK - Sri Lanka 1
MY - Malesia 1
NG - Nigeria 1
NZ - Nuova Zelanda 1
PK - Pakistan 1
PT - Portogallo 1
TW - Taiwan 1
Totale 3.961
Città #
Fairfield 350
Santa Clara 282
Southend 266
Woodbridge 261
Chandler 256
Ann Arbor 169
Ashburn 169
Houston 168
Jacksonville 162
Seattle 123
Wilmington 120
Cambridge 104
Nyköping 104
Dearborn 95
Singapore 76
Modena 32
San Diego 31
Fremont 30
Hong Kong 30
New York 29
Princeton 27
Helsinki 26
Eugene 25
Sofia 25
Beijing 23
Izmir 21
Falls Church 17
Bremen 14
Des Moines 11
Redwood City 11
Brussels 10
London 9
Toronto 9
Shanghai 8
Boardman 7
Hefei 6
San Mateo 6
Auburn Hills 5
Munich 5
Nanjing 5
Norwalk 4
Augusta 3
Dallas 3
Hounslow 3
Kilburn 3
Leawood 3
Milan 3
Parma 3
Philadelphia 3
Bangalore 2
Chongqing 2
Delhi 2
Dongguan 2
Frankfurt am Main 2
Grafing 2
Guangzhou 2
Islington 2
Jinan 2
Kolkata 2
Kraków 2
Los Angeles 2
Marburg 2
Monmouth Junction 2
Ottawa 2
San Giuliano Milanese 2
Taiyuan 2
Amsterdam 1
Ardabil 1
Bagnolo San Vito 1
Bhavnagar 1
Bologna 1
Brno 1
Buenos Aires 1
Castelnuovo Rangone 1
Colombo 1
Denver 1
Dublin 1
Genova 1
Hangzhou 1
Hanover 1
Indiana 1
Karachi 1
Kiev 1
Kuala Lumpur 1
Kunming 1
Lawrence 1
Lisbon 1
Maceió 1
Markham 1
Mountain View 1
Mumbai 1
Nanchang 1
Reston 1
Saint Petersburg 1
Sant'Ilario d'Enza 1
Shenyang 1
Stockholm 1
Taipei 1
Tappahannock 1
Tauranga 1
Totale 3.223
Nome #
Cisplatin-resistance modulates the effect of protein synthesis inhibitors on spermidine/spermine N-1-acetyltransferase expression 240
Clusterin decreases oxidative stress in lung fibroblasts exposed to cigarette smoke 223
Differential induction of spermidine/spermine N1-acetyltransferase activity in cisplatin-sensitive and -resistant ovarian cancer cells in response to N1,N12-bis (ethyl)spermine involves transcriptional and post-transcriptional regulation. 216
Prognostic role of clusterin in resected adenocarcinomas of the lung. 205
Cell detachment and apoptosis induction of immortalized human prostate epithelial cells are associated with early accumulation of a 45 kDa nuclear isoform of clusterin 196
Chronic administration of green tea extract to TRAMP mice induces the collapse of Golgi apparatus in prostate secretory cells and results in alterations of protein post-translational processing 193
The chemopreventive action of catechins in the TRAMP mouse model of prostate carcinogenesis is accompanied by clusterin over-expression 184
Hyper-homocysteinemia alters amyloid peptide-clusterin interactions and neuroglial network morphology and function in the caudate after intrastriatal injection of amyloid peptides 184
Clusterin (SGP-2, ApoJ) expression is downregulated in low- and high-grade human prostate cancer 179
Coordinate changes of polyamine metabolism regulatory proteins during the cell cycle of normal human dermal fibroblasts 176
Clusterin (SGP-2) gene expression is cell cycle dependent in normal human dermal fibroblasts 169
Gene expression analysis in combination with clinical parameters is effective in predicting relapse after radical prostatectomy 160
Genetic inactivation of ApoJ/clusterin: effects on prostate tumourigenesis and metastatic spread 159
Manipulation of the expression of regulatory genes of polyamine metabolism results in specific alterations of the cell-cycle progression 155
Increased levels of clusterin (SGP-2) mRNA and protein accompany rat ventral prostate involution following finasteride treatment 151
LIVER ORNITHINE DECARBOXYLASE ACTIVITY IN THE EUROPEAN SEA BASS (DICENTRARCHUS LABRAX L.):EFFECTS OF PROTEIN COMPOSITION OF THE DIET,ENVIRONMENTAL CONDITIONS AND AGE 142
Clusterin (SGP-2) transient overexpression decreases proliferation rate of SV40-immortalized human prostate epithelial cells by slowing down cell cycle progression 136
Clusterin is down-regulated during the progression of prostate cancer in the tramp mouse model but up-regulated during chemioprevention by green tea catechins administration 131
Clusterin gene expression is down-regulated in transformed epithelial cells but up-regulated in fibroblasts from prostate cancer 125
GENE RELAXATION AND AGING - CHANGES IN THE ABUNDANCE OF RAT VENTRAL PROSTATE SGP-2 (CLUSTERIN) AND ORNITHINE DECARBOXYLASE MESSENGER-RNAS 121
Effects of CLU knock down on prostate cancer progression in the TRAMP model. 119
CADMIUM INDUCTION OF RENAL AND HEPATIC ORNITHINE DECARBOXYLASE ACTIVITY IN THE RAT - EFFECTS OF SEX-HORMONES AND INVOLVEMENT OF THE RENIN-ANGIOTENSIN SYSTEM 118
Molecular classification of green tea catechin-sensitive and green tea catechin-resistant prostate cancer in the TRAMP mice model by quantitative real-time PCR gene profiling 106
Tumor progression is accompanied by significant changes in the levels of expression of polyamine metabolism regulatory genes and clusterin (sulfated glycoprotein 2) in human prostate cancer specimens (vol 60, pg 28, 2000) 104
BLOCKADE OF ALFA AND BETA-ADRENERGIC RECEPTORS CAN PREVENT STIMULATION OF LIVER ORNITHINE DECARBOXYLASE ACTIVITY BY GLUCOCORTICOID AND LAPARATOMY 102
Totale 3.994
Categoria #
all - tutte 17.516
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 17.516


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020508 0 0 0 0 0 116 126 69 85 21 46 45
2020/2021600 40 38 50 44 69 28 40 90 17 113 42 29
2021/2022519 5 84 54 33 15 18 33 19 45 27 117 69
2022/2023576 64 76 44 75 56 93 3 66 55 2 11 31
2023/2024227 10 16 18 14 51 40 7 18 6 7 29 11
2024/2025450 42 9 21 77 208 93 0 0 0 0 0 0
Totale 3.994